- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/52 - CytokinesLymphokinesInterferons
Patent holdings for IPC class C07K 14/52
Total number of patents in this class: 1706
10-year publication summary
|
88
|
104
|
113
|
107
|
113
|
99
|
111
|
108
|
93
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20410 |
25 |
| Regeneron Pharmaceuticals, Inc. | 4531 |
24 |
| Yale University | 2470 |
21 |
| The Trustees of the University of Pennsylvania | 4387 |
18 |
| The Board of Trustees of the Leland Stanford Junior University | 6589 |
17 |
| Vib VZW | 883 |
17 |
| The General Hospital Corporation | 4796 |
15 |
| Genentech, Inc. | 4045 |
14 |
| Memorial Sloan-Kettering Cancer Center | 1992 |
13 |
| Universiteit Gent | 1364 |
13 |
| Lipoxen Technologies Limited | 43 |
12 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3256 |
12 |
| Arla Foods amba | 549 |
11 |
| Institute for Research in Biomedicine (IRB) | 39 |
11 |
| Washington University | 1672 |
11 |
| Ith Immune Therapy Holdings | 15 |
11 |
| Akamis bio, Inc. | 28 |
11 |
| Osaka University | 3355 |
10 |
| Wake Forest University Health Sciences | 727 |
10 |
| Immunitybio, Inc. | 487 |
10 |
| Other owners | 1420 |